TP53 and myelodysplastic syndrome: In this study, we have established that induction of both WT and mutant TP53 expression influences erythroid cell lipid composition, differentiation, and ferroptosis sensitivity, each of which can play crucial roles in DBA and MDS patient outcomes [9,24].